Last Update 02 Apr 26

Fair value Decreased 4.12%

SYF: Future P/E Reset Will Reflect Credit Card Rate Cap Risks

Synchrony Financial's updated analyst price target reflects a modest reset, with fair value shifting from $74.31 to $71.25 as analysts incorporate slightly lower profit margins and valuation multiples, while still acknowledging the stated revenue growth assumptions in a more cautious sector backdrop.

Analyst Commentary

Recent research on Synchrony reflects a shift toward more cautious positioning, with several bearish analysts trimming price targets and reassessing where the stock should trade in light of sector wide pressures and changing assumptions.

Across the card and broader consumer finance group, research notes highlight concerns around an uncertain macro backdrop, potential regulatory changes to credit card rates, and questions about how resilient loan growth and credit performance will be. These factors are feeding into lower valuation multiples and more conservative earnings assumptions for Synchrony.

At the same time, there are still firms expressing confidence in the name, as seen in earlier upgrades and higher price targets that were based on expectations for stable fundamentals, resilient consumers, and what some described as a benign credit environment. The latest round of revisions, however, leans more guarded than those earlier, more optimistic views.

Investors looking at this mix of opinions are essentially weighing whether recent target cuts and list removals are signaling concerns about execution and growth durability, or whether they simply reflect a reset after a period of stronger sentiment and higher multiples across specialty finance.

Bearish Takeaways

Bearish analysts have lowered Synchrony targets by various amounts, including recent cuts of $12, $13, $8, $6, $4, $2 and $8, reflecting more conservative assumptions around margins, earnings power and the multiples they are willing to apply to the stock.
The removal of Synchrony from a major firm’s best ideas list suggests that, for some, the risk and reward balance has tilted away from a high conviction view, with concerns that sector headwinds could limit upside relative to other financials.
Research pointing to consumer finance coverage flirting with bear market territory, and to tougher sentiment around card issuers, highlights worries that investors may question the durability of growth, especially if AI related employment concerns or off network spending trends persist.
References to a proposed 10% cap on credit card interest rates, even when framed as a low probability risk, underline regulatory uncertainty that could weigh on valuation, as investors factor in the possibility of pressure on profitability and access to credit should such measures advance.

What's in the News

JPMorgan CEO publicly warned that a proposed 10% cap on credit card rates could be a "disaster" for the industry, highlighting regulatory risk that is directly relevant to Synchrony and other card issuers (Reuters).
Synchrony expanded its CareCredit pet health reimbursement solution through a new partnership with Figo Pet Insurance, giving pet owners the option to have approved Figo claims reimbursed directly to their CareCredit accounts and extending CareCredit's pet insurance ecosystem to more than 1,200,000 insured policyholders.
The company renewed its long running financing partnership with Polaris Inc., continuing to provide promotional financing and loans across Polaris' U.S. dealer network, with access to Synchrony's PRISM credit decisioning system for underwriting.
A new partnership with Weave will integrate CareCredit into Weave's platform so healthcare practices can view CareCredit status, initiate payments in office or via text to pay, and allow patients to apply for credit within Weave. The initiative aims to simplify patient financing and reduce deferred care.
Synchrony expanded its agreement with Planet DDS, making CareCredit the preferred patient financing solution across Denticon and Cloud 9 platforms and marking its first integration with an orthodontic specific practice management system. This integration is expected to streamline financing workflows for thousands of practices.

Valuation Changes

Fair Value: trimmed from $74.31 to $71.25, a reduction of about 4%, reflecting slightly lower modeled profitability and valuation multiples.
Discount Rate: adjusted from 9.12% to 9.03%, a small change that modestly affects how future cash flows are weighed.
Revenue Growth: updated from 18.22% to 18.41%, a minor upward revision to the long term top line growth assumption using dollar revenue.
Net Profit Margin: moved from 17.04% to 16.92%, indicating a slight reduction in expected profitability based on dollar earnings.
Future P/E: lowered from 9.81x to 9.40x, signaling a more conservative multiple applied to projected earnings.

2 views

Key Takeaways

Decline in purchase volume and credit actions present risks to future earnings and profitability.
Rising costs and macroeconomic uncertainties could lead to weaker revenue outlook and margin compression.
Synchrony's diverse product suite, partnerships, data-driven strategies, and strong capital position may enhance growth, profitability, and resilience.

Catalysts

About Synchrony Financial

Operates as a consumer financial services company in the United States.What are the underlying business or industry changes driving this perspective?

Synchrony's purchase volume has been negatively impacted by credit actions and selective customer spending behavior, leading to a significant decline in net revenue, which could imply lower future earnings if purchase volume does not rebound.
The risk of macroeconomic uncertainty, such as potential tariffs, may further dampen consumer confidence and spending, resulting in a weaker revenue outlook and potential margin compression if costs cannot be controlled.
The company's provision for credit losses has decreased due to reserve releases, which may not be sustainable if economic conditions worsen, potentially leading to increased credit costs and reduced profitability.
Synchrony's expansion and renewal of partnerships with new and existing partners come at a potential risk of higher costs or lower pricing power, which could squeeze net margins if competitive pressures increase.
Despite investments in technology and enhancements to customer experience, rising expenses related to these initiatives could outpace revenue growth in an inflationary environment, leading to deteriorating net margins and lower future earnings.

Synchrony Financial Earnings and Revenue Growth

Synchrony Financial Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

This narrative explores a more pessimistic perspective on Synchrony Financial compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts.
The bearish analysts are assuming Synchrony Financial's revenue will grow by 18.4% annually over the next 3 years.
The bearish analysts assume that profit margins will shrink from 35.6% today to 16.9% in 3 years time.
The bearish analysts expect earnings to reach $2.7 billion (and earnings per share of $10.75) by about April 2029, down from $3.5 billion today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $3.5 billion.
In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 9.4x on those 2029 earnings, up from 6.8x today. This future PE is greater than the current PE for the US Consumer Finance industry at 8.1x.
The bearish analysts expect the number of shares outstanding to decline by 7.0% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 9.03%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Synchrony's ability to consistently engage customers and drive loyalty through its diverse product suite and sophisticated underwriting could lead to increased revenues and earnings.
The renewal and addition of significant partnerships, such as those with Sun Country Airlines and American Eagle, may drive growth in purchase volume and positively impact net margins.
The company's data-driven approach in managing consumer spending and payment behaviors could lead to lower credit loss provisions, thereby benefiting net earnings.
Synchrony's strong net interest margins, supported by lower interest-bearing liabilities costs and increased loan receivable yields, may enhance profitability.
The robust capital position and strategic capital return plans, including share repurchases and dividend increases, can provide resilience and potentially improve earnings per share.

Valuation

How have all the factors above been brought together to estimate a fair value?

The assumed bearish price target for Synchrony Financial is $71.25, which represents up to two standard deviations below the consensus price target of $88.7. This valuation is based on what can be assumed as the expectations of Synchrony Financial's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $103.0, and the most bearish reporting a price target of just $71.0.
In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be $16.2 billion, earnings will come to $2.7 billion, and it would be trading on a PE ratio of 9.4x, assuming you use a discount rate of 9.0%.
Given the current share price of $68.32, the analyst price target of $71.25 is 4.1% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Synchrony Financial?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Credit Actions And Tariffs Will Squeeze Net Margins